We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have updated the reimbursement routes and added new market insights for 2023/24.
An introductory guide to European market access and reimbursement stakeholders and processes
In this introductory guide, our Global market access experts present an overview of the reimbursement landscape in key European healthcare systems.
We highlight the differences between key markets and provide a high-level guide for those looking to bring innovative Pharmaceutical interventions to Europe.
The guide offers an overview of national reimbursement processes and market innovations in:
- France
- Great Britain
- Germany
- Italy
- Spain
Please complete the form to request your copy. Access to this guide is at the discretion of the Mtech Access Team.
Introductory guide: Market access and reimbursement in key European markets
Complete the form to request your copy
This guide focuses on reimbursement routes for Pharma interventions. Looking to understand more about access routes for medical devices? Check out our other guide: Market access stakeholders and processes for medical devices in key European markets.
To learn more about how to plan the best route to market in Europe and develop your global market access and pricing strategy,
